Purpose
to support novel TB drug regimen clinical trials through integration of person-centered outcomes into TB trial statistics.
Grantee
Division
Global Health
Date
JUNE 2026
Region served
GLOBAL
Committed amount
$1,428,624
Grant topic
Tuberculosis
Duration (months)
32
Grantee location
San Francisco, California, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.